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Background: Pathogen transmission from contaminated surfaces can cause hospital-associated infec-
tions. Although pulsed xenon ultraviolet (PX-UV) light devices have been shown to decrease hospital room
bioburden in the United States, their effectiveness in United Kingdom (UK) hospitals is less understood.
Methods: Forty isolation rooms at the Queens Hospital (700 beds) in North London, UK, were sampled
for aerobic bacteria after patient discharge, after manual cleaning with a hypochlorous acid–troclosene
sodium solution, and after PX-UV disinfection. PX-UV device eﬃcacy on known organisms was tested by
exposing inoculated agar plates in a nonpatient care area. Turnaround times for device usage were re-
corded, and a survey of hospital staff for perceptions of the device was undertaken.
Results: After PX-UV disinfection, the bacterial contamination measured in colony forming units (CFU)
decreased by 78.4%, a 91% reduction from initial bioburden levels prior to terminal cleaning. PX-UV ex-
posure resulted in a 5-log CFU reduction for multidrug-resistant organisms (MDROs) on spiked plates.
The average device turnaround time was 1 hour, with minimal impact on patient throughput. Ward staff
were enthusiastic about device deployment, and device operators reported physical comfort in usage.
Conclusions: PX-UV use decreased bioburden in patient discharge rooms and on agar plates spiked with
MDROs. The implementation of the PX-UV device was well received by hospital cleaning and ward staff,
with minimal disruption to patient ﬂow.
© 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier
Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
Health care–associated infections are estimated to cost the UKNa-
tional Health Service (NHS) >£1 billion a year.1 Infections caused by
multidrug-resistant organisms (MDROs) and other hospital-associated
infections (HAIs) are associated with increased morbidity and
mortality and are among themany challenges faced by hospitals striv-
ing for better patient safety.2 Despite the successes in the UK over
the last decade in reducing the burden of some infections, such as
Clostridium diﬃcile infection and methicillin-resistant Staphylococ-
cus aureus (MRSA) bloodstream infection, infection prevention and
control continues to be challenging in hospitals. Austerity mea-
sures, increasing population demands for care, and emerging infection
threats, such as from carbapenemase-producing Enterobacteriaceae
(CPE), require innovative approaches to maintain quality and safety.
The environment provides a reservoir for pathogenic organ-
isms and plays an important role in the transmission of infections,
particularly in outbreak situations.3,4 Therefore, decontamination of
patient care areas is now considered to be vital in a comprehen-
sive infection prevention and control program5 and is critical in
preventing transmission of norovirus and C diﬃcile.6
There may be signiﬁcant variation in the way manual cleaning
with chemicals is performed and its effectiveness, partly because
of the complexity of the environment in which these activities take
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place.6-8 For instance, a study showed that up to 50% of high-
touch surfaces within patient areas are oftenmissed during chemical
cleaning because of inaccessibility and human error.9 Therefore, new
technologies have begun to be investigated to help supplement the
cleaning process with the intention of achieving better assurance
of environmental decontamination.10-13
Multiple no-touch disinfection devices have been developed for
environmental decontamination, and many of these systems are
being suggested for adoption in health care facilities in the United
States as part of standard decontamination protocols.14,15 One such
no-touch disinfection method involves ultraviolet in the C spec-
trum light-emitting devices, which use ultraviolet-C light between
the wavelengths of 200 and 320 nm, the biocidal spectrum.16
Pulsed xenon ultraviolet (PX-UV) light devices (Xenex, San
Antonio, TX) have been described previously and studies in the
United States indicate microbiologic eﬃcacy of the PX-UV device,17-19
but the health care environment in the UK is challenging, with a
decreasing hospital bed base and a need for faster patient dis-
charges, less single rooms, and signiﬁcant ﬁnancial constraints.
Therefore, the purpose of the current study was to evaluate the en-
vironmental eﬃcacy and feasibility of using this no-touch technology
within daily patient care activities in a UK hospital.
METHODS
This prospective study was conducted from July 2014-November
2014 at Queens Hospital (700 beds), a NHS hospital in the Barking,
Havering, and Redbridge University Hospitals group in North London,
UK, serving a population with a signiﬁcant elderly proportion with
many comorbidities. The study was approved by the hospital’s re-
search board. A convenience sample of 40 hospital rooms was
selected for this study. Three main outcomes were studied: micro-
biologic eﬃcacy of the PX-UV device on aerobic bacterial counts,
time taken for disinfection, and staff attitudes to the new technology.
Microbiologic eﬃcacy
A comparative study was designed to evaluate the eﬃcacy of the
PX-UV device in reducing environmental contamination in
postdischarge patient isolation rooms by sampling 5 high-touch sur-
faces before standard terminal cleaning, after standard terminal
cleaning, and after PX-UV disinfection. Patient rooms were se-
lected from acute medical assessment units A and B (there were 6
rooms in each unit). The study rooms were identiﬁed through the
infection prevention and control database and were selected for use
by infection prevention and control staff. The inclusion criteria speci-
ﬁed for the study rooms were as follows: (1) it must have been a
single occupancy room, (2) it must have been occupied for a
minimum of 48 hours, (3) it must have been recently vacated on
the same day as the sample collection, and (4) it must have been
used as a contact isolation room.
Once the room was identiﬁed, baseline microbiologic samples
were collected after patient discharge but before standard termi-
nal cleaning. Five high-touch surfaces (bedrail, bathroom handrail,
tray table, toilet seat, and bathroom faucet handle) were sampled
using 5-mm diameter Trypticase Soy Agar contact plates (Oxoid,
Basingstoke, UK). For ﬂat surfaces the press plate methodwas used,20
and for curved surfaces a rolling plate technique was used to ensure
coverage of the appropriate surface area. After the initial sam-
pling, hospital cleaners performed standard terminal cleaning, using
a 1,000 ppm (0.1%) chlorine disinfectant (Actichlor Plus; Ecolab,
Cheshire, UK), prepared using 1 effervescent tablet mixed with 1 L
of water to produce a hypochlorous acid disinfectant solution with
detergent (troclosene sodium). Once the terminal cleaning was com-
pleted and surfaces were dry, the second set of environmental
samples was collected. Finally, the PX-UV device was deployed and
then subsequent environmental samples were taken from the same
5 surfaces. PX-UV device operators and cleaning staff were blinded
to the chosen sampling surfaces to prevent any bias or changes in
cleaning practices. After sample collection, the Trypticase Soy Agar
contact plates were returned to the laboratory, incubated in air at
37°C for 48 hours, and enumerated per the manufacturer’s recom-
mendations with the number of colony forming units (CFU) being
recorded. Aerobic bacteria, including MRSA, vancomycin-resistant
enterococci (VRE), and CPE, will form colonies on Trypticase Soy Agar
contact plates, but anaerobic bacteria such as C diﬃcile will not.
In each hospital room, the PX-UV device was deployed for 3
cycles: two 5-minute cycles in the living room (1 cycle on each side
of the patient bed) and one 5-minute cycle in the bathroom.
The eﬃcacy of the PX-UV device was also evaluated by seeding
agar plates with hospital clinical isolates of MRSA, VRE, multidrug-
resistant Acinetobacter, and CPE. Suspensions of each organismwere
produced by inoculating the isolate into 5 mL of saline to McFar-
land turbidity 0.5-1.0. The Miles and Misra method21 was used for
dilution so that the CFUs postincubation could be counted by eye.
Agar plates were divided into 6 equal sectors, and 20 μL of each di-
lution of organismwas dropped onto the surface of separate sectors
(ie, 1 agar plate had 6 dilutions for one of the test organisms.) Each
drop was allowed to spread naturally, and plates were left upright
on the bench to air-dry before inversion. In total, 3 sets of plates
for each organism were prepared. One set of plates for each organ-
ism was immediately incubated once air-dried for 24 hours in air
at 37°C as a control. The other 2 sets of plates for each organism
were immediately taken to a sluice room (used for body ﬂuid discard;
also called a dirty utility room). The agar plates were placed at a
surface 20 in above ﬂoor level adjacent to each other and at 1.2 m
distance from the PX-UV device in the line of sight. One set of plates
for each organismwas kept covered (further control plate); the other
was uncovered (test plate). All plates were exposed to PX-UV light
for a 10-minute cycle. All plates were then incubated in air at 37°C
for 24 hours.
Analysis of microbiologic samples
Means and frequencies described the total number CFU before
and after standard terminal cleaning and after using the PX-UV
device, overall and by surface location. Wilcoxon signed-rank tests
were used to assess a change in CFU between baseline and after stan-
dard terminal cleaning for each surface location. Similarly, a change
in CFU after standard terminal cleaning and after the PX-UV device
use was assessed (Table 1). To examine a reduction in the pres-
ence of CFU with standard terminal cleaning versus no cleaning, or
PX-UV disinfection versus standard terminal cleaning, the McNemar
test was used to test the null hypothesis of marginal homogenei-
ty. Evidence supporting the alternative hypothesis would suggest
that one cleaning method was superior to the other (Table 2). For
the seeded agar plates, CFU were recorded and CFU per milliliter
were calculated (CFU/mL = number of colonies of a dilution × 50 ×
dilution factor).
Time studies
To determine the impact of the PX-UV device on isolation room
decontamination times (and hence room availability), time studies
of the movement and use of the device were conducted. A stan-
dard log was used to record when the device was collected from
the storage area, how long the device was left waiting at the room
before use, device in-use time, and device return time to storage.
Device transport time was standardized to represent the time
it takes for the operator to walk from the storage area to the targeted
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ward area with the PX-UV device. This transport time was re-
corded for every device deployment from storage facility to the target
ward or room. In-room device use time was taken to also include
any arranging of furniture. Of the sampled rooms, 31 had valid times
recorded for each of the steps noted (Table 3).
Staff perceptions
A survey component was used to gauge staff attitudes toward
the use of the new technology, including 3 device operators and 12
clinical ward staff members. Each of the surveys (one for opera-
tors and a separate survey for other staff) contained 4 Likert scale
questions, ranging from responses of strongly disagree (or very dif-
ﬁcult) to strongly agree (very easy). Agree-type responses (agree
and strongly agree) were combined to denote whether or not staff
agreed with the statement. Similarly, easy responses (easy and very
easy) were combined to determine the ease of use for the PX-UV
machine (Table 4). A type I error of α = 0.05 was assumed through-
out. All analyses were performed using SAS version 9.2 (SAS Institute,
Cary, NC).
RESULTS
Patient rooms
One roomwas discarded from analysis for not having PX-UV dis-
infection information, reducing the sample to 39 rooms. Table 1
provides a summary of the recovered bioburden from the patient
environment postdischarge, after standard terminal cleaning, andTa
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Table 2
Proportion of samples with CFU present at baseline, after terminal cleaning, and after
PX-UV disinfection, overall and by surface location (39 rooms)
Surface location
No. of
pairs
Baseline,
n (%)
Terminal clean,
n (%), P value*
PX-UV,
n (%), P value*
Bedrail 28 26 (92.9) 10 (35.7), <.01 2 (7.1), .01
Tray table 39 29 (74.4) 17 (43.6), <.01 3 (7.7), <.01
Bathroom handrail 39 32 (82.1) 23 (59.0), .02 7 (18.0), <.01
Toilet Seat 39 35 (89.7) 26 (66.7), .01 12 (30.8), <.01
Bathroom faucet 39 36 (92.3) 27 (69.2), .01 6 (15.4), <.01
Combined 184 158 (85.9) 103 (56.0), <.01 30 (16.3), <.01
CFU, colony forming units; PX-UV, pulsed xenon ultraviolet.
*Change in presence assessed with McNemar test, assuming a type I error of α = 0.05.
Table 3
Description of CFU counts per sample
Surface Status n Mean ± SD Median (min-max)
Bedrail Baseline 28 16.2 ± 20.1 9.0 (0-100)
Manual 28 1.6 ± 3.9 0.0 (0-20)
PX-UV 28 0.5 ± 2.0 0.0 (0-10)
Tray table Baseline 39 9.6 ± 15.1 3.0 (0-70)
Manual 39 2.6 ± 4.8 0.0 (0-23)
PX-UV 39 0.5 ± 2.7 0.0 (0-17)
Bathroom handrail Baseline 39 11.6 ± 11.5 9.0 (0-48)
Manual 39 9.6 ± 22.6 3.0 (0-100)
PX-UV 39 1.5 ± 4.0 0.0 (0-20)
Toilet seat Baseline 39 31.2 ± 33.2 19.0 (0-100)
Manual 39 12.4 ± 22.1 4.0 (0-100)
PX-UV 39 5.0 ± 17.3 0.0 (0-100)
Bathroom faucet Baseline 39 27.9 ± 33.9 15.0 (0-100)
Manual 39 10.1 ± 15.4 5.0 (0-70)
PX-UV 39 0.8 ± 2.1 0.0 (0-8)
Combined Baseline 184 19.5 ± 26.1 10.0 (0-100)
Manual 184 7.6 ± 16.8 2.0 (0-100)
PX-UV 184 1.7 ± 8.5 0.0 (0-100)
CFU, colony forming units; max, maximum; min, minimum; PX-UV, pulsed xenon
ultraviolet.
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after PX-UV disinfection for the surface locations of bed rail, tray
table, bathroom handrail, toilet seat, and bathroom faucet. The great-
est reduction was observed for the toilet seat (median reduction,
10 CFU; P < .01), followed by the bathroom faucet (reduction, 8 CFU;
P < .01). The use of PX-UV disinfection further reduced bioburden
for the tray table, bathroomhandrail, toilet seat, and bathroom faucet.
The greatest reduction with PX-UV disinfection after terminal clean-
ing was observed for the bathroom faucet (median reduction, 4 CFU;
P < .01), followed by the bathroomhandrail (reduction, 2 CFU; P < .01).
Both standard terminal cleaning and PX-UV disinfection after ter-
minal cleaning appeared to be effective in the reduction of rooms
with any CFU present (Table 2). The greatest proportion of con-
taminated rooms at baseline was observed for bedrail surfaces (93%),
which was reduced the most after terminal cleaning to 36%. PX-
UV disinfection after terminal cleaning appeared to further decrease
the proportion of rooms contaminated by at least half for all 5 sur-
faces (ranging from 54% for the toilet seat to 82% for the tray table).
Table 3 provides a description of CFU per sample. Average CFU
for all sample sites were 19.5 (median, 10) CFU per contact plate
(55 mm in diameter) at discharge. On standard terminal cleaning,
average CFU per plate decreased 61% to 7.6 (median, 2) CFU per
contact plate. After disinfection with the PX-UV device, the average
CFU per plate decreased by 78% to an average of 1.7 (median, 0) CFU
per plate, a 91% reduction from the initial levels.
Spiked plates in the sluice room
The control plates incubated directly at 37°C in air showed con-
ﬂuent growth of colonies. Similarly, the covered inoculated plates
that were exposed to PX-UV disinfection (the cover blocks expo-
sure to PX-UV) as previously described also showed conﬂuent
growth; however, the plates that were not shielded from PX-UV dis-
infection showed 1 colony of MRSA, 6 colonies of VRE, 7 colonies
of multidrug-resistant Acinetobacter, and 3 colonies of CPE, indi-
cating a 5-log reduction in colony counts on exposure to PX-UV light
in the sluice room.
Time studies
Table 4 provides the time breakdown for speciﬁc tasks in-
volved in PX-UV device use in room decontamination. The results
recorded are from the perspective of the PX-UV device user and sum-
marized by mean, median, and range. The median time for total PX-
UV device deployment from retrieval to storage was 50 minutes.
Retrieving and returning the device took approximately 5-6minutes.
Another 10 minutes were generally used for waiting to use the
device. The actual PX-UV treatment time was approximately 20
minutes, which included rearranging furniture in the room and 3
locations for device use, taking up roughly one-third of the entire
process.
Staff perceptions
Overall, cleaning staff were enthusiastic about PX-UV device usage
and were willing to make adjustments to their existing schedules
to accommodate its use. PX-UV operators all agreed that they felt
comfortable using the device; two-thirds found moving the device
easy, and one-third found the setup process to be easy (Table 5).
Other hospital staff and patients were curious about the PX-UV device
when it was seen in the clinical area, and they were supportive of
its use after being given an explanation of its purpose.
None of the clinical ward staff felt the machine caused a noise
disturbance or that it was disruptive to staff or patients. However,
1 staff member (8.3%) felt turnaround time was affected.
DISCUSSION
Increasingly, innovative no-touchdisinfection devices are being used
throughout health care arenas to providemore assurance of the clean-
liness of hospital environments. The PX-UV device is one such no-
touch disinfection device that is in use in the United States. However,
there is limited published research on its implementation in the UK
health care system. Our results demonstrate 3 main ﬁndings:
1. The failure of standard terminal cleaning (combined manual
cleaning and chemical disinfection) of isolation rooms to ade-
quately removemicrobial contamination from the environment.
2. The PX-UV system signiﬁcantly reduced microorganisms from
common high-touch surfaces within patient isolation rooms and
associated bathrooms.
3. The PX-UV device was easily incorporated into terminal de-
contamination protocols for isolation rooms within busy clinical
areas and did not adversely affect patient throughput.
It is now accepted that a cleaner patient environment can reduce
HAIs by reducing microbial contamination with less transmission
of pathogens including MDROs to patients.5 This is of particular im-
portance when considering an isolation room because a new
occupant may acquire pathogens from the environment whose orig-
inal source was a previous occupant.22 Our ﬁndings show that the
initial bioburden recorded at 5 high-touch surfaces was reduced by
terminal cleaning and further reduced by PX-UV application. When
all sample locations were compiled, bioburden was reduced from
a mean precleaning level of 19.5 CFU per contact plate to 7.6 after
terminal cleaning and to 1.7 after PX-UV use, equivalent to a 61%
reduction by terminal cleaning alone and a 78% reduction after PX-
UV disinfection. The toilet seat and bathroom faucet showed the
greatest reduction in bioburden overall. These ﬁndings could have
particular signiﬁcance when considering patients displaying symp-
toms of C diﬃcile infection because these high-touch areas would
Table 4
Time for PX-UV device deployment (31 rooms)
Process Mean ± SD (min) Median (min-max) (min)
Transport to room time 24.8 ± 17.9 20 (10-100)
Retrieval time 7.1 ± 3.2 5 (0-15)
Waiting time for use 17.7 ± 17.6 10 (5-90)
In-room use time 21.4 ± 15.4 20 (5-86)
Return to storage time 13.2 ± 16.8 6 (0-70)
Total time 59.4 ± 27.7 50 (35-135)
max, maximum; min, minimum; PX-UV, pulsed xenon ultraviolet.
Table 5
Survey responses from device operators (n = 3) and other clinical ward staff (n = 12)
Question Agree
Device operator
Q1. Moving machine (easy) 2 (66.7)
Q2. Set-up process (easy) 1 (33.3)
Q3. Comfortable using 3 (100)
Q4. Others commented 3 (100)
Clinical ward staff
Q1. Use caused noise disturbance 0 (0.0)
Q2. Use caused disruption 0 (0.0)
Q3. Use impacted turnaround time 1 (8.3)
Q4. Patients commented on machine 7 (58.3)
NOTE. Values are n (%).
Q, question.
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be suspected to be contaminated with the bacteria and spores;
however, C diﬃcile was not investigated as part of this study. The
activity of the PX-UV device against MDROs was undertaken in a
sluice roomwhere the environment was expected to be heavily con-
taminated prior to exposure, rather than a patient care area, as in
another study,23 which could compromise patient safety through
exposure to live cultures. There was a 5-log reduction in MDRO bac-
terial counts after the use of the PX-UV device for 10 minutes,
highlighting the potential effectiveness against these signiﬁcant
causes of HAI that could contaminate the hospital environment.
The enhanced level of disinfection was achieved during everyday
hospital operationswithnegligible interruption to patient care andﬂow.
Hospital cleaning staff were able to effectively incorporate the PX-UV
device as a no-touch disinfection approach into daily routine practice.
There are a few unique aspects to this study. Most previous
studies conducted with PX-UV devices have been performed in the
United States; this one however was conducted in the UK. This
creates distinctive variables when compared with previous studies,
including differences in hospital room layout, cleaning protocols,
and hospital populations. With all of these local variables, the PX-
UV device was shown to be effective at decreasing the bioburden
in hospital isolation rooms. The results experienced in our study
are similar to bioburden decrease seen in U.S. studies.14,15,18,19,24,25 The
pressure for beds in the UK NHS also necessitates that isolation room
decontamination must be both quick and effective to maintain
patient ﬂow without compromising patient safety. Therefore, rapid
and effective decontamination of an empty patient room was a key
consideration of hospital ward staff as part of this study, particu-
larly when considering, generally, isolation rooms are fewer in
number in UK hospital wards compared with the United States.
Previous studies have discussed the time taken to run the device,
but this study was able to record total retrieval to storage time as
approximately 1 hour, with the PX-UV device use taking 20 minutes
of the total time. The utilization of the device did not signiﬁcantly
increase the time taken to terminally decontaminate isolation rooms,
and this was supported by the feedback from clinical ward staff with
overall opinion of the device being relatively high—only 1 staff
member reported that room turnaround time was affected on what
were the most busy hospital wards.
Improvements could focus on strategic placement of devices to
reduce transport time and nondisinfection and idle time if incorpora-
tion into standard hospital practice was considered. C diﬃcilewas not
included as a speciﬁc pathogen in this study;when considering the de-
mographics of the population the study hospital serves, this could
provide valuable data. The use of the PX-UV device inmultioccupancy
ward settings should alsobe investigated, particularly in outbreakswhen
patients are cohorted into 4-6 patient occupancyward bays. Our study
is limited in the number of staff surveyed, and this is an area for future
exploration. This study shows that no-touch, PX-UV device usage could
be translated to a different health setting, which may bear consider-
ation because MDROs pose an international threat.
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